» Journals » J Pharm Pharm Sci

Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques

The Journal of Pharmacy & Pharmaceutical Sciences is a publication of the Canadian Society for Pharmaceutical Sciences. It covers a wide range of topics in the field of pharmacy and pharmaceutical sciences, including drug discovery, drug delivery systems, pharmacokinetics, and clinical pharmacy. The journal aims to provide a platform for researchers, scientists, and practitioners to share their latest findings and advancements in the field.

Details
Abbr. J Pharm Pharm Sci
Start 1998
End Continuing
Frequency Three no. a year
e-ISSN 1482-1826
Country Switzerland
Language English
Specialties Pharmacology
Pharmacy
Metrics
h-index / Ranks: 3798 88
SJR / Ranks: 7262 619
CiteScore / Ranks: 3928 5.90
JIF / Ranks: 3958 2.7
Recent Articles
1.
Meng F, Qiao X, Xin C, Ju X, He M
J Pharm Pharm Sci . 2025 Feb; 28:14083. PMID: 39935622
[This corrects the article DOI: 10.3389/jpps.2024.12434.].
2.
de Assis Ramos M, Ricardo-da-Silva F, Macedo L, Correia C, Moreira L, Lobenberg R, et al.
J Pharm Pharm Sci . 2024 Dec; 27:13633. PMID: 39619127
17β-estradiol (E2) is an endogenous steroid hormone pivotal for the development of female secondary sexual characteristics and the maintenance of the female reproductive system. Its roles extend beyond these physiological...
3.
Madrid Sani A, Ramos-Rocha K, Sarcinelli M, Chaves M, Rocha H, Leo P, et al.
J Pharm Pharm Sci . 2024 Oct; 27:13635. PMID: 39469425
The COVID-19 pandemic has raised concern regarding respiratory system diseases and oral inhalation stands out as an attractive non-invasive route of administration for pulmonary diseases such as chronic bronchitis, cystic...
4.
5.
Kwon S, Jeyaratnam R, Kim K
J Pharm Pharm Sci . 2024 Oct; 27:13375. PMID: 39403635
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disorder marked by excessive accumulation of lipids within the liver. If untreated, this condition can progress to metabolic dysfunction-associated steatohepatitis (MASH),...
6.
Naja K, Anwardeen N, Bashraheel S, Elrayess M
J Pharm Pharm Sci . 2024 Oct; 27:13305. PMID: 39355646
Background: Sulfonylureas have been a longstanding pharmacotherapy in the management of type 2 diabetes, with potential benefits beyond glycemic control. Although sulfonylureas are effective, interindividual variability exists in drug response....
7.
Dianatkhah M, Salami H, Soltani R, Hosseini A
J Pharm Pharm Sci . 2024 Sep; 27:13343. PMID: 39329163
The present study evaluated the rational prescription of linezolid, the prevalence of thrombocytopenia, and major drug interactions in patients with cardiovascular diseases. We conducted a retrospective cross-sectional study on linezolid-treated...
8.
Liu Y, Un E, Bai Y, Chan M, Zeng L, Lei S, et al.
J Pharm Pharm Sci . 2024 Aug; 27:13206. PMID: 39211421
Fetal growth restriction (FGR) is associated with a higher risk of perinatal morbidity and mortality, as well as long-term health issues in newborns. Currently, there is no effective medicine for...
9.
Shafaati T, Gopal K
J Pharm Pharm Sci . 2024 Aug; 27:13193. PMID: 39206323
Cardiovascular disease including diabetic cardiomyopathy (DbCM) represents the leading cause of death in people with diabetes. DbCM is defined as ventricular dysfunction in the absence of underlying vascular diseases and/or...
10.
Inoue Y, Yoshino K, Kudo S, Kodama N, Moteki H, Kimura M
J Pharm Pharm Sci . 2024 Aug; 27:13230. PMID: 39193564
Purpose: To investigate the preparation of inclusion complexes of diphenylcyclopropenone (DPCP)/β-cyclodextrin (β-CD) derivatives using a three-dimensional (3D) ball mill, and verify the inclusion behavior of the solid dispersion. Additionally, we...